Preparation and Evaluation of a Freeze-dried Kit of ~(99)Tc~m-rituximab for Sentinel Lymph Node Imaging

LI Yan,LI Nan,ZHAI Shi-zhen,WANG Xue-juan,YANG Zhi

2011-01-01

Abstract:99Tcm-rituximab has been demonstrated to be having favourable properties for sentinel lymph node imaging.The aim of this research was to develop the formulation of the 99Tcm-rituximab freeze-dried kit.Firstly the rituximab was modified by 2-Mercapitoethanol,with the glucose as the excipient,and 1 mL phosphate buffers to compose the kit,which was dispensed into nitrogen-filled vials and aliquots frozen at-20 ℃.99Tcm-Rituximab was prepared from the 99Tcm-glucose via ligand exchange method.Both of the labeling yield and the radiochemical purity were more than 90%.The results of biodisdistribution of 99Tcm-rituximab in normal rat with front pad injection showed that the accumulation of the sentinel lymph node increased from 1 h(0.93±0.39%ID) to 4 h(2.14±0.46%ID).The ratio of the uptake of sentinel lymph node to that of the injection site was 14.80±2.11% at 4 h,with no significant change at 18 h(13.03%±3.98%).The SPECT imaging in rat showed that the sentinel lymph node can be seen clearly without the secondary lymph node imaging 30 min~18 h p.i..In general,the frozen kit of rituximab was feasible to prepare the sentinel imaging agent 99Tcm-rituximab,which possesses satisfied properties for sentinel lymph node SPECT imaging.